Using AI to aid in cancer diagnosis, Proscia raises $37 million

Proscia
By Author Proscia | June 14, 2022

Proscia announced a $37 million round of funding from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital, along with existing investors Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers, and Razor’s Edge Ventures. This is Procia’s first funding since it raised a $23 million round in late 2020, and the new investment brings its total funding to $72 million.

Since it’s last funding round, the company has launched new products, including Automated QC, an automated quality control application that leverages AI to improve quality and efficiency in data-driven drug development, which was released earlier this year.

Our website uses cookies. By using this site, you agree to its use of cookies.